Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03275402
Title 131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Y-mAbs Therapeutics
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | ESP | DNK

Facility Status City State Zip Country Details
Childrens Hospital Los Angeles Los Angeles California 90027 United States Details
Riley Hospital for Children Indianapolis Indiana 46202 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Nationwide Children's Hospital Columbus Ohio 43205 United States Details
M.D. Anderson Cancer Center Houston Texas 77030 United States Details
Rigshospitalet København 2100 Denmark Details
Department of Pediatric Oncology Fukushima Medical University Hospita Fukushima City 960-1295 Japan Details
Hospital Sant Joan de Déu Barcelona 08010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field